Single Dose Omeprazole Versus High Dose in High-risk Critically Ill Patients.

NACompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

May 11, 2016

Primary Completion Date

August 14, 2017

Study Completion Date

September 17, 2017

Conditions

Critical Illness

Interventions

DRUG

Omeprazole

Omeprazole 80 mg continues infusion

DRUG

Placebo group

Omeprazole 40 mg single daily dose.

All Listed Sponsors

lead

Menoufia University

OTHER

NCT03388463 - Single Dose Omeprazole Versus High Dose in High-risk Critically Ill Patients. | Biotech Hunter | Biotech Hunter